Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Raw Materials (2016 - 2022)

Biomerica's Raw Materials history spans 11 years, with the latest figure at $1.4 million for Q1 2022.

  • For Q1 2022, Raw Materials fell 3.68% year-over-year to $1.4 million; the TTM value through Feb 2022 reached $1.4 million, down 3.68%, while the annual FY2021 figure was $1.6 million, 3.18% down from the prior year.
  • Raw Materials for Q1 2022 was $1.4 million at Biomerica, down from $1.4 million in the prior quarter.
  • Across five years, Raw Materials topped out at $2.2 million in Q3 2020 and bottomed at $989000.0 in Q3 2018.
  • The 5-year median for Raw Materials is $1.3 million (2019), against an average of $1.4 million.
  • The largest annual shift saw Raw Materials surged 82.33% in 2020 before it tumbled 32.72% in 2021.
  • A 5-year view of Raw Materials shows it stood at $1.1 million in 2018, then grew by 12.89% to $1.2 million in 2019, then skyrocketed by 44.58% to $1.7 million in 2020, then fell by 18.99% to $1.4 million in 2021, then dropped by 3.95% to $1.4 million in 2022.
  • Per Business Quant, the three most recent readings for BMRA's Raw Materials are $1.4 million (Q1 2022), $1.4 million (Q4 2021), and $1.5 million (Q3 2021).